Ameritas Investment Partners’s PDL BioPharma, Inc. PDLI Stock Holding History

Ameritas Investment Partners’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,974	Closed	-$31K	–	3148
2020 Q3	$31K	Hold	9,974	–	–	﹤0.01%	2153
2020 Q2	$29K	Hold	9,974	–	–	﹤0.01%	2155
2020 Q1	$28K	Hold	9,974	–	–	﹤0.01%	1998
2019 Q4	$32K	Hold	9,974	–	–	﹤0.01%	2172
2019 Q3	$22K	Sell	9,974 -2,690	-21%	-$7.19K	﹤0.01%	2352
2019 Q2	$40K	Hold	12,664	–	–	﹤0.01%	2040
2019 Q1	$47K	Hold	12,664	–	–	﹤0.01%	1920
2018 Q4	$37K	Hold	12,664	–	–	﹤0.01%	1992
2018 Q3	$33K	Hold	12,664	–	–	﹤0.01%	2240
2018 Q2	$30K	Hold	12,664	–	–	﹤0.01%	2294
2018 Q1	$37K	Hold	12,664	–	–	﹤0.01%	2090
2017 Q4	$35K	Hold	12,664	–	–	﹤0.01%	2137
2017 Q3	$39K	Hold	12,664	–	–	﹤0.01%	2048
2017 Q2	$31K	Hold	12,664	–	–	﹤0.01%	2217
2017 Q1	$29K	Hold	12,664	–	–	﹤0.01%	2190
2016 Q4	$27K	Hold	12,664	–	–	﹤0.01%	1153
2016 Q3	$42K	Hold	12,664	–	–	﹤0.01%	1113
2016 Q2	$40K	Hold	12,664	–	–	﹤0.01%	1044
2016 Q1	$42K	Hold	12,664	–	–	﹤0.01%	1037
2015 Q4	$45K	Hold	12,664	–	–	﹤0.01%	1028
2015 Q3	$64K	Sell	12,664 -725	-5%	-$4.15K	﹤0.01%	992
2015 Q2	$85K	Sell	13,389 -1,727	-11%	-$11.6K	0.01%	1024
2015 Q1	$106K	Hold	15,116	–	–	0.01%	1053
2014 Q4	$116K	Buy	15,116 +725	+5%	+$5.74K	0.01%	1030
2014 Q3	$108K	Hold	14,391	–	–	0.01%	1007
2014 Q2	$139K	Buy	14,391 +2,180	+18%	+$19.4K	0.01%	1024
2014 Q1	$101K	Hold	12,211	–	–	0.01%	1019
2013 Q4	$103K	Hold	12,211	–	–	0.01%	1010
2013 Q3	$97K	Buy	+12,211	New	+$98.2K	0.01%	957

Other funds holding PDLI

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Ameritas Investment Partners's PDLI Position: Q4 2020 in Review

Ameritas Investment Partners sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 9,974 shares — an estimated $31K sold.

Ameritas Investment Partners first reported a position in PDLI in Q3 2013 and held it in 29 quarters. The position peaked at $139K in Q2 2014. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

Ameritas Investment Partners reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
Ameritas Investment Partners sold 9,974 PDL BioPharma, Inc. shares in Q4 2020, an estimated $31K.
Ameritas Investment Partners first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 29 quarters.
Ameritas Investment Partners's PDL BioPharma, Inc. position peaked at $139K in Q2 2014.
33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Ameritas Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.